As of 2025-09-18, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 44.19 USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.80 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -1.4%.
The range of the Relative Valuation is 35.61 - 53.32 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.0x - 39.9x | 35.2x |
| Forward P/E multiples | 27.9x - 38.7x | 34.8x |
| Fair Price | 35.61 - 53.32 | 44.19 |
| Upside | -20.5% - 19.0% | -1.4% |
| Date | P/E |
| 2025-09-12 | 39.52 |
| 2025-09-11 | 40.56 |
| 2025-09-10 | 40.17 |
| 2025-09-09 | 40.02 |
| 2025-09-08 | 39.83 |
| 2025-09-05 | 39.99 |
| 2025-09-04 | 39.49 |
| 2025-09-03 | 39.06 |
| 2025-09-02 | 38.72 |
| 2025-08-29 | 39.22 |
| 2025-08-28 | 39.44 |
| 2025-08-27 | 39.18 |
| 2025-08-26 | 38.53 |
| 2025-08-25 | 38.62 |
| 2025-08-22 | 39.02 |
| 2025-08-21 | 37.66 |
| 2025-08-20 | 37.10 |
| 2025-08-19 | 36.51 |
| 2025-08-18 | 37.37 |
| 2025-08-15 | 37.11 |
| 2025-08-14 | 36.66 |
| 2025-08-13 | 37.07 |
| 2025-08-12 | 35.85 |
| 2025-08-11 | 35.27 |
| 2025-08-08 | 35.84 |
| 2025-08-07 | 36.04 |
| 2025-08-06 | 36.89 |
| 2025-08-05 | 32.63 |
| 2025-08-04 | 32.21 |
| 2025-08-01 | 30.87 |
| 2025-07-31 | 30.51 |
| 2025-07-30 | 29.18 |
| 2025-07-29 | 29.08 |
| 2025-07-28 | 29.04 |
| 2025-07-25 | 29.19 |
| 2025-07-24 | 28.56 |
| 2025-07-23 | 28.66 |
| 2025-07-22 | 28.40 |
| 2025-07-21 | 28.89 |
| 2025-07-18 | 28.11 |
| 2025-07-17 | 29.20 |
| 2025-07-16 | 29.14 |
| 2025-07-15 | 29.13 |
| 2025-07-14 | 29.52 |
| 2025-07-11 | 28.79 |
| 2025-07-10 | 28.81 |
| 2025-07-09 | 28.40 |
| 2025-07-08 | 27.90 |
| 2025-07-07 | 27.34 |
| 2025-07-03 | 27.80 |